Young doctors, many of whom presented with sleep disturbances (often unrecognized), despite the absence of obesity, anxiety, depression, and relatively high social well-being, should incorporate routine monitoring of sleep parameters and non-pharmacological interventions in prevention programs for at least cardiovascul...
I. Kudryavtsev, A. Rumyantsev· Nephrology (Saint-Petersburg...· 0 citations
The potential for treating hypertension with an injectable drug based on small interfering ribonucleic acid called zilebesiran is being actively studied, and a single subcutaneous administration of zilebesiran resulted in a significant reduction in blood pressure, with the effect lasting for up to 6 months.
P. Filiniuk, A. Rumyantsev, I. Pchelin et al.· Vrach· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.